Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD

from Let’s Talk Ophthalmology: an Evolve Medical Education Podcast · host Evolve Medical Education, LLC

David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.

Episode metadata supplied by the publisher feed · Published Aug 15, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Adapting to Progress: Axitinib Intravitreal Implant for Wet AMD

0:00 11:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Let’s Talk Ophthalmology: an Evolve Medical Education Podcast?

This episode is 11 minutes long.

When was this Let’s Talk Ophthalmology: an Evolve Medical Education Podcast episode published?

This episode was published on August 15, 2024.

Can I download this Let’s Talk Ophthalmology: an Evolve Medical Education Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!